468 Enhancers and repressors of immunotherapy: translational perspectives on gene-mediated cytotoxic immunotherapy in glioblastoma

468 Enhancers and repressors of immunotherapy: translational perspectives on gene-mediated cytotoxic immunotherapy in glioblastoma

Bibliographic Details
Main Authors:	Sean Lawler, Marilin Koch, Mikolay Zdioruk, Estuardo Aguilar-Cordova, Laura Aguilar, Brian Guzik, Ghazaleh Tabatabai, Michal Nowicki, E Antonio Chiocca
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models
by: Aguilar, E., et al.
Published: (2022)

Advances in Immunotherapy for Adult Glioblastoma
by: Chirayu R. Chokshi, et al.
Published: (2021-07-01)

Putting Proteomics Into Immunotherapy for Glioblastoma
by: Liangyu Chen, et al.
Published: (2021-02-01)

Virus-Based Immunotherapy of Glioblastoma
by: Miika Martikainen, et al.
Published: (2019-02-01)

Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01)

Current Immunotherapies for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2021-03-01)

Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration
by: Michal O. Nowicki, et al.
Published: (2019-04-01)

Immunotherapy in Glioblastoma: A Clinical Perspective
by: Nicolas Desbaillets, et al.
Published: (2021-07-01)

Gamma-delta T cells in glioblastoma immunotherapy
by: Sadhak Sengupta
Published: (2019-01-01)

Overview of Cellular Immunotherapy for Patients with Glioblastoma
by: Elodie Vauleon, et al.
Published: (2010-01-01)

NK Cell-Based Glioblastoma Immunotherapy
by: Irene Golán, et al.
Published: (2018-12-01)

Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Miranda W. Yu, et al.
Published: (2021-05-01)

Glioblastoma Immune Landscape and the Potential of New Immunotherapies
by: Thomas Daubon, et al.
Published: (2020-10-01)

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
by: Ketao Jin, et al.
Published: (2021-01-01)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
by: Bas Weenink, et al.
Published: (2020-03-01)

Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme
by: Xun Xu, et al.
Published: (2012-01-01)

Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
by: Christopher Jackson, et al.
Published: (2011-01-01)

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme
by: Christopher Chin, et al.
Published: (2018-11-01)

Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
by: Karishma R. Rajani, et al.
Published: (2019-02-01)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Frontiers Production Office
Published: (2021-10-01)

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
by: Luke Maggs, et al.
Published: (2021-05-01)

Immunotherapy approach to combat nicotine addiction
by: Pashmi, Ghazaleh
Published: (2004)

Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment
by: S. V. Timofeeva, et al.
Published: (2021-06-01)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
by: Joshua R. D. Pearson, et al.
Published: (2020-10-01)

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
by: Minfeng Yang, et al.
Published: (2020-08-01)

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
by: Fiona A. Desland, et al.
Published: (2020-10-01)

Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma
by: Roxanne Wouters, et al.
Published: (2021-12-01)

Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
by: Jason Adhikaree, et al.
Published: (2020-01-01)

The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
by: Mira A. Patel, et al.
Published: (2014-09-01)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
by: Liu Yang, et al.
Published: (2015-01-01)

Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
by: Andrea eSchuessler, et al.
Published: (2014-10-01)

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy
by: Mélanie Rose, et al.
Published: (2021-09-01)

Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas
by: Sanjeev Chawla, et al.
Published: (2021-04-01)

Immunotherapy for recurrent glioblastoma: practical insights and challenging prospects
by: Xin Wang, et al.
Published: (2021-03-01)

HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
by: Marilin S. Koch, et al.
Published: (2020-11-01)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
by: Bernarda Majc, et al.
Published: (2021-01-01)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
by: Eliane Klein, et al.
Published: (2020-12-01)

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
by: Jingyu Wang, et al.
Published: (2020-01-01)

Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
by: Sadhak Sengupta, et al.
Published: (2014-01-01)

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01)